Diagnostic Yield and Economic Implications of Whole-Exome Sequencing for ASD Diagnosis in Israel
- Supplementary File 1:
ZIP-Document (ZIP, 23 KiB)
Tal-Ben Ishay, R.; Shil, A.; Solomon, S.; Sadigurschi, N.; Abu-Kaf, H.; Meiri, G.; Flusser, H.; Michaelovski, A.; Dinstein, I.; Golan, H.; Davidovitch, N.; Menashe, I. Diagnostic Yield and Economic Implications of Whole-Exome Sequencing for ASD Diagnosis in Israel. Genes 2022, 13, 36. https://doi.org/10.3390/genes13010036
Tal-Ben Ishay R, Shil A, Solomon S, Sadigurschi N, Abu-Kaf H, Meiri G, Flusser H, Michaelovski A, Dinstein I, Golan H, Davidovitch N, Menashe I. Diagnostic Yield and Economic Implications of Whole-Exome Sequencing for ASD Diagnosis in Israel. Genes. 2022; 13(1):36. https://doi.org/10.3390/genes13010036
Chicago/Turabian StyleTal-Ben Ishay, Rotem, Apurba Shil, Shirley Solomon, Noa Sadigurschi, Hadeel Abu-Kaf, Gal Meiri, Hagit Flusser, Analya Michaelovski, Ilan Dinstein, Hava Golan, Nadav Davidovitch, and Idan Menashe. 2022. "Diagnostic Yield and Economic Implications of Whole-Exome Sequencing for ASD Diagnosis in Israel" Genes 13, no. 1: 36. https://doi.org/10.3390/genes13010036